News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
It’s undeniably a new era in Bone Marrow Transplant – Shernan Holtan
Photo from teiko.bio
Jun 17, 2023, 15:23

It’s undeniably a new era in Bone Marrow Transplant – Shernan Holtan

Something I didn’t expect to see during my career: Severe acute and chronic Graft-versus host disease <6% in well-matched myeloablative transplantation. One death due to GVHD out of 125 patients, and that was too many. It’s undeniably a new era in Bone Marrow Transplant.

 

Source: Shernan Holtan /Twitter

Bone Marrow Transplant GVHD myeloablative transplantation Shernan Holtan
Special Coverage
Science
Jan 3, 2025, 16:58
Emmanuel S. Antonarakis: The two faces of FOXA1 mutations in prostate cancers
Science
Jan 3, 2025, 16:56
Richa Shah: My Forever Paper
Science
Jan 3, 2025, 16:51
Melinda Bachini: Advancing Patient-Centered Care in Transplant Oncology
Blog
Jan 3, 2025, 16:48
The NCI Cellular Cancer Biology Imaging Research Program
Blog
Jan 3, 2025, 16:40
Call for nominations for 2025 Arthur M. Sutherland Award and Memorial Lecture - IPOS
Career
Jan 3, 2025, 16:33
Amy de Haar-Holleman started as a Clinical Professor at Free University of Brussels
Science
Jan 3, 2025, 16:25
Amivantamab Plus Lazertinib in Patients With EGFR-mutant NSCLC by Benjamin Besse et al.
Science
Jan 3, 2025, 16:22
Expert consensus statement on the peri-operative management of NSCLC by Stephanie Saw et al.
Science
Jan 3, 2025, 16:17
Iannis Aifantis: Our short review/discussion of the Comazzetto and Morrison Ascorbate deficiency
Blog
Jan 3, 2025, 16:13
Early registration for GU25 closes on January 8th - ASCO
Blog
Jan 3, 2025, 15:57
High peripheral T cell diversity associated with lower risk of toxicity to dual ICI Therapy - JITC
Blog
Jan 3, 2025, 15:31
Gaia Griguolo: TOP1 Mutations are more frequent after treatment with ADCs